The data presented was last updated Oct. 21, 2017.
Here is the amount 10 pharmaceutical organizations spent on lobbying efforts so far this year.
1. Pharmaceutical Research & Manufacturers of America ($19.8 million)
2. Amgen ($8.6 million)
3. Pfizer ($8.5 million)
4. Bayer ($7.05 million)
5. Novartis ($7.04 million)
6. Eli Lilly ($5.55 million)
7. Merck ($5.44 million)
8. Teva Pharmaceuticals ($4.71 million)
9. AbbVie ($4.38 million)
10. Sanofi ($4.19 million)
More articles on supply chain:
Survey: 61% of patient advocacy groups have favorable view of devicemakers
Baxter expects $70M revenue loss from Hurricane Maria
Survey: 61% of patient advocacy groups have favorable view of devicemakers
